International Alfapump Cohort Study (TOPMOST)

Sequana Medical

Status: Active, not recruiting

Conditions: Liver Cirrhoses; Malignant Ascites

Treatments: Device: Alfapump

Study type: Observational

Funder types: Industry

Identifiers

NCT04326946

2019-AAR-012

Details and patient eligibility

About

This Registry is designed to follow patients who have been implanted with an alfapump system, which is a newly marketed product from Sequana Medical AG, a Swiss Medical Device company.

Full description

In a real-world setting, all patients implanted with an alfapump system according to it's intended use, not participating in another clinical study in which the alfapump is studied.

Enrollment: 400 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients implanted with an alfapump are eligible for this registry

Exclusion criteria

• Patients younger than 18 years
• Pregnancy
• Inability to operate the Smart Charger to recharge the alfapump
• Participating in another study in which the alfapump is studied